Definition of and mechanism for opioid-induced sedation

Pain Management Nursing

Volumn 2, Issue 3, 2001, Pages 84-97

  Young McCaughan, Stacey ^a   Miaskowski, Christine ^b  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALFENTANIL; ANTI ANXIETY AGENTS, BENZODIAZEPINE; ANXIOLYTIC AGENT; BENZODIAZEPINE; BREMAZOCINE; BRL 52656; BRL 53001; DIAZEPAM; DUP 747; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETHYLKETAZOCINE; FENTANYL; KAPPA OPIATE RECEPTOR AGONIST; KETOCYCLAZONE; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 CYSTEINE]; LORAZEPAM; METHADONE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALTRINDOLE; NARCOTIC ANALGESIC AGENT; OPIATE; PLACEBO; RIMCAZOLE; S 73894; SPIRADOLINE; SUFENTANIL; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; AROUSAL; ARTICLE; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; CONSCIOUSNESS; CONTROLLED STUDY; DENTAL ANESTHESIA; DRUG COMBINATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MALE; NONHUMAN; PHYSIOLOGY; RAT; SEDATION; SIDE EFFECT;

EID: 0035160426     PISSN: 15249042     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpmn.2001.25012     Document Type: Article

References (97)

1. Alteration in level of responsiveness: A proposed nursing diagnosis
2. Sleep and its abnormalities
3. Clinical implications of a quality of life perspective on the multidimensional nature of pain in the patient with cancer
4. Anatomical organization of the central nervous system
5. Delirium, dementia, and amnestic and other cognitive disorders
6. Morphine-induced deficits in sleep patterns: Attenuation by glucose
7. Methods for monitoring the level of sedation
8. Intravenous opioid anesthetics
9. Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time
10. Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids
11. Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry
12. Pain and analgesia
13. Pharmacological considerations for conscious sedation: Clinical applications of receptor function
14. Electroencephalographic effects of sufentanil anaesthesia in man
15. Induction of anesthesia with small doses of sufentanil or fentanyl: Dose versus EEG response, speed of onset, and thiopental requirement
16. Amplitude and spectral quantification of the effects of morphine on the cortical EEG of the rat
17. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer
18. Methylphenidate associated with narcotics for the treatment of cancer pain
19. The use of methylphenidate in patients with incident cancer pain receiving regular opiates: A preliminary report
20. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain
21. Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain
22. Effects of highly selective κ-agonists on EEG power spectra and behavioural correlates in conscious rats
23. Practical issues in the management of cancer pain
24. Power spectral analysis of EEG during sufentanil infusion in humans
25. Alertness, cognition and morphine in patients with advanced cancer
26. Selecting a nursing diagnosis for changes in consciousness
27. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist
28. Potentiation of opioid analgesia by psychostimulant drugs: A review
29. Cortical potential evoked by tooth pulp stimulation differentiate between the analgesic and sedative effects of morphine in awake rats
30. Brain monoamines are involved in the sedative effects of opiates and neuroleptics
31. The effect of diazepam and fentanyl on mental, psychomotor and electroencephalographic functions and their rate of recovery
32. Altered level of consciousness: Validity of a nursing diagnosis
33. Determination of receptors that mediated opiate side effects in the mouse
34. A comparison of cognitive impairment due to benzodiazepines and to narcotics
35. Sleep and dreaming
36. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats
37. Narcotics in the elderly
38. Adjunctive treatment of insomnia with hypnotic drugs
39. Adverse effects of commonly ordered oral narcotics
40. Morphine effects on human REM state, waking state and NREM sleep
41. Effects of β-endorphin and morphine on the sleep-wakefulness behavior of cats
42. A modern neurobiological concept of vigilance
43. What is the effect of peripheral and central acting analgesic agents on the sleep patterns of arthritic rats?
44. Pharmacology of intravenous sedatives and opioids in critically ill patients
45. Pharmacologic management of cancer pain
46. Differential changes of laser evoked potentials, late auditory evoked potentials and P300 under morphine in chronic pain patients
47. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain
48. Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones
49. Pharmacology of opioids
50. Genetic profiles of morphine-induced EEG, EEG power spectra, and behavior in two inbred rat strains
51. Pain mechanisms: A new theory
52. Altered levels of responsiveness: Decreased response
53. Benzodiazepine receptor: Demonstration in the central nervous system
54. The benzodiazepine receptor: A pharmacological control element of brain function
55. Brain stem reticular formation and activation of the EEG
56. Thalamic contributions to attention and consciousness
57. Physiology of arousal: Moruzzi and Magoun's ascending reticular activating system
58. The normal EEG of the waking adult
59. Sleep and EEG
60. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity
61. The pathologic physiology of signs and symptoms of coma
62. What every neuroanesthesiologist should know about electroencephalograms and computerized monitors
63. Sleep and dreaming
64. Opioid analgesics and antagonists
65. The brain stem: Cranial nerve nuclei and the monoaminergic systems
66. Delirium: Phenomenologic and etiologic subtypes
67. Pharmacology of spinal opioids
68. Monitored anesthesia care
69. Electroencephalographic quantification of opioid effect: Comparative pharmacodynamics of fentanyl and sufentanil
70. EEG quantification of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil
71. Effects of high-dose fentanyl anesthesia on the electroencephalogram
72. Sedative doses of propofol increase beta activity of the processed electroencephalogram
73. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids
74. Continuous reaction time after single dose, long-term oral and epidural opioid administration
75. A critique of instruments and methods to detect, diagnose, and rate delirium
76. EEGs during high-dose fentanyl-, sufentanil-, or morphine-oxygen anesthesia
77. Effect of physiotherapy on the auditory evoked response of paralyzed, sedated patients in the intensive care unit
78. Mu-delta opioid interactions I: The delta peptide, DPDPE, increases morphine-induced EEG and EEG spectral power
79. Mu-delta opioid interactions III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole
80. Peripheral mechanisms of opioid analgesia
81. Thalamocortical oscillations in the sleeping and aroused brain
82. Concept analysis methodology: Applications to altered level of consciousness
83. 2-methionine-enkephalinamide and morphine in the rat
84. Consciousness: A neurobiological approach
85. Benzodiazepine side effects: Role of pharmacokinetics and pharmacodynamics
86. Drug effects on REM sleep and on endogenous depression
87. Electroencephalographic effects of fentanyl-, sufentanil- and alfentanil anaesthesia in man
88. Opioid analgesics and antagonists
89. Enkephalin opens potassium channels on mammalian central neurones
90. A randomized, cross-over evaluation of methylphenidate in cancer patients receiving strong narcotics
91. Spinal opiate analgesia: Characteristics and principles of action
92. Methylphenidate or dextroamphetamine as adjuvants in opioid analgesia
93. Comparative effects of the kappa opioid agonists U-50,488H, spiradoline and DuP 747 on EEG, EEG power spectra and behavior
94. Interactions between U- 50,488H and & receptor antagonists: EEG, EEG power spectral and behavioral correlates
95. Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectral in the rat: Stereospecificity and naloxone antagonism